Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients

Not Applicable

Completed

• Conditions: Cancer; Lymphoma; Leukemia; Stem Cell Transplantation
• Interventions: Behavioral: Tailored assessments provided to physicians and nurses (CHOICE, the Computer-assisted Interactive Tailored Patient Assessment Tool (ITPA))

• Registration Number: NCT00709813
• Lead Sponsor: Oslo University Hospital

Brief Summary

Patient-provider shared decision making and the inclusion of patients' illness experiences and preferences in patient care are prioritized areas in health care. CHOICE is a computer-based support system for patient-centered symptom management of cancer patients developed for this purpose. In this randomized clinical trial at Rikshospitalet- Radiumhospitalet HF 145 adult stem-cell transplantation and newly diagnosed lymphoma and leukemia patients used CHOICE for assessments of their symptoms, problems and priorities for care at in-and outpatient visits during treatment and rehabilitation. In the experimental group this information was shared with physicians an nurses for subsequent care planning, but not in the control group.

This study tested effects of CHOICE on symptom- related patient care and outcomes of symptom relief, patients' needs for care over time and patient satisfaction;(2) analyzed how patients' symptoms, needs for care varied during illness/treatment stages; and (3) evaluated CHOICE' ease of use and user satisfaction. Controlling for gender, age, diagnosis, and type/stage of treatment, education, depression, health related quality of life, and social support, repeated measurement models were used to test differences and variations in outcome variables within and between groups and over time.

Detailed Description

as above

Study Timeline

• Study Start: 2003-12
• Primary Completion: 2005-12
• Study Completion: 2005-12
• Study First Submitted: 2008-07-02
• Study First Submitted QC: 2008-07-02
• Study First Posted: 2008-07-03
• Status Verified: 2009-03
• Last Update Submitted: 2011-07-03
• Last Update Posted: 2011-07-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 145

Inclusion Criteria

• Starting treatment for a newly diagnosed acute myelogenous leukemia (AML), lymphatic leukemia (ALL), Hodgkin or non-Hodgkin lymphoma, or
• starting treatment for a recurrence of the disease;
• starting treatment with allogenous or autologous Stem Cell Transplantation (SCT).
• above 18 years of age.

Exclusion Criteria

• having received radiation on the brain

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
2	Tailored assessments provided to physicians and nurses (CHOICE, the Computer-assisted Interactive Tailored Patient Assessment Tool (ITPA))	-

Primary Outcome Measures

Name	Time	Method
Physicians' and nurses' symptom-related chart entries in patients' records	In-patient episodes of care
Symptom distress over time	Repeated episodes of care
Patients' prioritized needs for care over time	Repeated episodes of care

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction	End of study
Care providers' satisfaction	End of study
Preferences for participation in decision making- and changes over time	Baseline, and at completion of treatment